Status:
COMPLETED
Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Lead Sponsor:
Kahramanmaras Sutcu Imam University
Conditions:
Cerebral Palsy
Infant, Premature, Diseases
Eligibility:
All Genders
25-42 years
Brief Summary
High risk infant is defined as infant with a negative history of environmental and biological factors, which can lead to neuromotor development problems. It is a heterogeneous group of premature infan...
Detailed Description
High-risk infants may encounter many problems in terms of motor, cognitive, sensory, social, and academic development. Premature and LBW infants are at higher risk in terms of motor and cognitive deve...
Eligibility Criteria
Inclusion
- Have periventricular hemorrhage, ICH stages 2, 3, 4, cystic PVL, stage 3 HIE, kernicterus, perinatal asphyxia, chronic lung disease, RDS, BPD, long-term oxygen (7 days), \>24 hours mechanical ventilator (MV) support, 5th minute Apgar Score \<3, neonatal sepsis, necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP), gestation age \<32 weeks, and prematurity due to preterm/multiple births\<1500 gr.
Exclusion
- Infants with congenital malformation (Spina Bifida, Congenital Muscular Torticollis, Arthrogriposis Multiplex Congenita etc.)
- Infants diagnosed with metabolic and genetic diseases (Down Syndrome,Spinal Muscular Atrophy, Duchenne Muscular Dystrophy etc.)
- Infants still intubated and mechanical ventilator dependent at postterm 3 months.
Key Trial Info
Start Date :
September 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2021
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT05217186
Start Date
September 15 2020
End Date
October 15 2021
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hatice Adiguzel
Kahramanmaraş, Dulkadiroglu, Turkey (Türkiye), 46100